AI-Powered Drug Discovery & Development Platforms

Comprehensive analysis of AI-native drug discovery: 15 leading platforms, validation data, and partnership economics.

Pages312

FormatPDF

LicenseSingle user

Updates12 months

Downloads38

Report scope

✓ Executive summary & key findings

✓ Market size & growth projections (2026–2032)

✓ Competitive landscape & company profiles

✓ Technology assessment & readiness levels

✓ Regional analysis (NA, EU, APAC, RoW)

✓ Regulatory environment & policy impacts

✓ Value chain & supply analysis

✓ Investment & M&A activity

✓ Strategic recommendations

✓ Methodology & data sources

Deep analysis of AI/ML in pharmaceutical R&D covering target identification, molecule design, ADMET prediction, and clinical trial optimization. Platform profiles: Recursion, Insitro, Exscientia, Atomwise, BenevolentAI, Tempus. Big pharma partnership economics and IPO/M&A activity. Regulatory considerations under FDA AI/ML SaMD framework.

Individual purchase $5,200 or ₹434,000

With subscription Included in professional+ plans

Start free trial Sign in